MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits
Clinical Review

New Drug Review from MPR (October 2013)

1.00 Credits

Archived CME/CE Courses


MPR Drug News

First Ebola Case Confirmed in NYC

According to the New York City Health Department, a volunteer medical aid worker who served in Guinea has tested positive for Ebola since his return to the United States.

FDA: Certain Auto-Injectors OK to Use 1 Year Beyond Exp Date

The FDA is alerting healthcare professionals and emergency responders that certain lots of AtroPen (atropine), CANA (diazepam), morphine sulfate, and pralidoxime chloride auto-injectors manufactured by Meridian Medical Technologies can be used for up to one year beyond the labeled expiration date.

Obizur Approved for Acquired Hemophilia A

Baxter announced that the FDA has approved Obizur (antihemophilic factor [recombinant], porcine sequence) for the treatment of bleeding episodes in adults with acquired hemophilia A.

Antiarrhythmic Agent Sotylize Gets FDA Approval

Arbor announced that the FDA has approved Sotylize (sotalol HCl) oral solution for the treatment of documented life-threatening ventricular arrhythmias and the maintenance of normal sinus rhythm in patients with a history of highly symptomatic atrial fibrillation/flutter.

CitraNatal Basic, OTC Pre-Pregnancy Supplement Launched

Mission Pharmacal announced the launch of CitraNatal basic, an over-the-counter (OTC) prenatal vitamin for pre-pregnancy nutritional support.